US Stock MarketDetailed Quotes

Impact BioMedical (IBO)

Watchlist
  • 0.6450
  • -0.0181-2.73%
Close Apr 17 16:00 ET
  • 0.6446
  • -0.0004-0.06%
Post 19:33 ET
69.54MMarket Cap-1.70P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Impact BioMedical (IBO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
33.78%-1.89M
110.04%99K
38.76%-613K
-80.26%-694K
-41.49%-682K
-0.11%-2.85M
-127.71%-986K
-49.18%-1M
47.48%-385K
52.47%-482K
Net income from continuing operations
52.08%-11.87M
119.29%5.24M
-134.74%-1.47M
-1,527.32%-14.35M
-28.06%-1.28M
-462.06%-24.77M
-2,051.70%-27.13M
460.49%4.24M
21.25%-882K
-17.55%-998K
Operating gains losses
--12K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
2.32%1.15M
2.51%286K
2.49%288K
3.23%288K
1.07%283K
-0.09%1.12M
-0.36%279K
0.36%281K
-0.36%279K
0.00%280K
Deferred tax
-7,918.18%-2.58M
----
----
----
----
--33K
----
----
----
----
Other non cash items
359.08%10.37M
295.66%9.39M
-7.75%262K
60.14%450K
17.83%271K
---4M
---4.8M
--284K
--281K
--230K
Change In working capital
198.68%600K
231.31%541K
130.22%42K
109.52%6K
83.33%11K
-239.45%-608K
-175.18%-412K
-161.50%-139K
-158.88%-63K
101.35%6K
-Change in receivables
-100.78%-1K
--10K
-111.72%-15K
----
----
200.00%128K
--0
36.17%128K
----
----
-Change in inventory
--7K
--3K
--1K
----
----
--0
--0
--0
----
----
-Change in prepaid assets
147.55%126K
-37.00%63K
89.16%-35K
102.50%1K
4,950.00%97K
-354.81%-265K
4.17%100K
-559.18%-323K
-129.41%-40K
97.47%-2K
-Change in payables and accrued expense
199.36%468K
190.82%465K
62.50%91K
91.30%-2K
-1,175.00%-86K
-202.39%-471K
-188.28%-512K
-69.06%56K
-135.38%-23K
102.19%8K
Cash from discontinued investing activities
Operating cash flow
33.78%-1.89M
110.04%99K
38.76%-613K
-80.26%-694K
-41.49%-682K
-0.11%-2.85M
-127.71%-986K
-49.18%-1M
47.48%-385K
52.47%-482K
Investing cash flow
Cash flow from continuing investing activities
50.00%3K
1K
0.00%1K
0
1K
113.33%2K
0
200.00%1K
109.09%1K
0
Net PPE purchase and sale
----
----
----
----
----
--0
--0
--0
--0
--0
Net other investing changes
50.00%3K
--1K
0.00%1K
--0
--1K
-33.33%2K
--0
--1K
----
----
Cash from discontinued investing activities
Investing cash flow
50.00%3K
--1K
0.00%1K
--0
--1K
113.33%2K
--0
200.00%1K
109.09%1K
--0
Financing cash flow
Cash flow from continuing financing activities
-102.25%-109K
-134.38%-109K
0
0
0
69.28%4.85M
36.64%317K
321.38%3.67M
-48.53%384K
-52.51%483K
Net issuance payments of debt
-109.70%-109K
-134.38%-109K
--0
--0
--0
-60.77%1.12M
36.64%317K
-106.90%-60K
-48.53%384K
-52.51%483K
Net common stock issuance
--0
--0
----
----
----
--3.73M
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
-102.25%-109K
-134.38%-109K
--0
--0
--0
69.28%4.85M
36.64%317K
321.38%3.67M
-48.53%384K
-52.51%483K
Net cash flow
Beginning cash position
199,800.00%2M
-99.55%12K
31,100.00%624K
65,800.00%1.32M
199,800.00%2M
-50.00%1K
1,227.36%2.67M
-33.33%2K
100.00%2K
-50.00%1K
Current changes in cash
-199.90%-2M
98.65%-9K
-122.96%-612K
---694K
-68,200.00%-681K
199,900.00%2M
-234.50%-669K
1,246.46%2.67M
--0
200.00%1K
End cash Position
-99.85%3K
-99.85%3K
-99.55%12K
31,100.00%624K
65,800.00%1.32M
199,800.00%2M
199,800.00%2M
1,227.36%2.67M
-33.33%2K
100.00%2K
Free cash flow
33.78%-1.89M
110.04%99K
38.76%-613K
-80.26%-694K
-41.49%-682K
0.52%-2.85M
-127.71%-986K
-48.96%-1M
48.32%-385K
52.70%-482K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 33.78%-1.89M110.04%99K38.76%-613K-80.26%-694K-41.49%-682K-0.11%-2.85M-127.71%-986K-49.18%-1M47.48%-385K52.47%-482K
Net income from continuing operations 52.08%-11.87M119.29%5.24M-134.74%-1.47M-1,527.32%-14.35M-28.06%-1.28M-462.06%-24.77M-2,051.70%-27.13M460.49%4.24M21.25%-882K-17.55%-998K
Operating gains losses --12K------------------------------------
Depreciation and amortization 2.32%1.15M2.51%286K2.49%288K3.23%288K1.07%283K-0.09%1.12M-0.36%279K0.36%281K-0.36%279K0.00%280K
Deferred tax -7,918.18%-2.58M------------------33K----------------
Other non cash items 359.08%10.37M295.66%9.39M-7.75%262K60.14%450K17.83%271K---4M---4.8M--284K--281K--230K
Change In working capital 198.68%600K231.31%541K130.22%42K109.52%6K83.33%11K-239.45%-608K-175.18%-412K-161.50%-139K-158.88%-63K101.35%6K
-Change in receivables -100.78%-1K--10K-111.72%-15K--------200.00%128K--036.17%128K--------
-Change in inventory --7K--3K--1K----------0--0--0--------
-Change in prepaid assets 147.55%126K-37.00%63K89.16%-35K102.50%1K4,950.00%97K-354.81%-265K4.17%100K-559.18%-323K-129.41%-40K97.47%-2K
-Change in payables and accrued expense 199.36%468K190.82%465K62.50%91K91.30%-2K-1,175.00%-86K-202.39%-471K-188.28%-512K-69.06%56K-135.38%-23K102.19%8K
Cash from discontinued investing activities
Operating cash flow 33.78%-1.89M110.04%99K38.76%-613K-80.26%-694K-41.49%-682K-0.11%-2.85M-127.71%-986K-49.18%-1M47.48%-385K52.47%-482K
Investing cash flow
Cash flow from continuing investing activities 50.00%3K1K0.00%1K01K113.33%2K0200.00%1K109.09%1K0
Net PPE purchase and sale ----------------------0--0--0--0--0
Net other investing changes 50.00%3K--1K0.00%1K--0--1K-33.33%2K--0--1K--------
Cash from discontinued investing activities
Investing cash flow 50.00%3K--1K0.00%1K--0--1K113.33%2K--0200.00%1K109.09%1K--0
Financing cash flow
Cash flow from continuing financing activities -102.25%-109K-134.38%-109K00069.28%4.85M36.64%317K321.38%3.67M-48.53%384K-52.51%483K
Net issuance payments of debt -109.70%-109K-134.38%-109K--0--0--0-60.77%1.12M36.64%317K-106.90%-60K-48.53%384K-52.51%483K
Net common stock issuance --0--0--------------3.73M--0------------
Cash from discontinued financing activities
Financing cash flow -102.25%-109K-134.38%-109K--0--0--069.28%4.85M36.64%317K321.38%3.67M-48.53%384K-52.51%483K
Net cash flow
Beginning cash position 199,800.00%2M-99.55%12K31,100.00%624K65,800.00%1.32M199,800.00%2M-50.00%1K1,227.36%2.67M-33.33%2K100.00%2K-50.00%1K
Current changes in cash -199.90%-2M98.65%-9K-122.96%-612K---694K-68,200.00%-681K199,900.00%2M-234.50%-669K1,246.46%2.67M--0200.00%1K
End cash Position -99.85%3K-99.85%3K-99.55%12K31,100.00%624K65,800.00%1.32M199,800.00%2M199,800.00%2M1,227.36%2.67M-33.33%2K100.00%2K
Free cash flow 33.78%-1.89M110.04%99K38.76%-613K-80.26%-694K-41.49%-682K0.52%-2.85M-127.71%-986K-48.96%-1M48.32%-385K52.70%-482K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -